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012.09.00Abstract Introduction: The enthesopathy of seronegative spondyloarthropathies (SpA) is the hall-
mark of these diseases, the ultrasound examination of these entheses conﬁrms the frequency of their
involvement.
Aim of the work: To detect entheseal abnormalities with ultrasound (US) in the lower limb of
patients with early spondyloarthropathy (SpA) and to evaluate US as a valuable tool in detecting
early enthesis.
Patients and methods: A total of 45 patients with early disease duration of 11.7 ± 8.5 months,
including 10 patients with psoriatic arthritis (PsA), 10 patients with ankylosing spondylitis (AS),
10 patients with reactive arthritis (ReA), eight patients with ulcerative colitis (UC) and seven
patients with Crohn’s disease and 20 healthy controls of matched age and sex underwent ultraso-
nographic evaluation of Achilles, quadriceps, patellar entheses and plantar aponeurosis. Ultrasono-
graphic ﬁndings were scored according to the Glasgow Ultrasound Enthesitis Scoring System
(GUESS).
Results: On US examination a total of 290/450 (64.4%) of the entheseal sites were abnormal.
Mean GUESS score was signiﬁcantly higher in patients with SpA as compared with controlscom (Y. Ezzat).
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30 Y. Ezzat et al.(p< 0.001), with a higher mean value in patients with PsA, ReA and AS. The mean thickness of all
tendons examined was signiﬁcantly higher in SpA patients than in controls (p< 0.0001) as well as
the mean number of enthesophytes and bursitis in all sites examined (p= 0.002, p= 0.003), with a
higher prevalence amongst patients with PsA and ReA. The GUESS score was correlated to dura-
tion of the disease and the anti-tumour necrosis factor alpha medications.
Conclusion: Enthesis involvement occurs early in spondyloarthritis, the enthesis US score
appears to be reliable and useful for improving the diagnostic accuracy of early SpA, further studies
are needed as US is an evolving technique.
 2012 Egyptian Society for Joint Diseases and Arthritis. Production and hosting by Elsevier B.V.
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The seronegative spondyloarthropathies comprise a group of
related inﬂammatory arthritides, the principal clinical entities
of this group include ankylosing spondylitis (AS), psoriatic
arthritis (PsA), reactive arthritis (ReA), enteropathic spondyli-
tis (inﬂammatory bowel disease). All of them demonstrate the
absence of serum rheumatoid factor (seronegativity), associa-
tion with the human leucocyte antigen B27 (HLA-B27), famil-
ial clustering, predominant axial and peripheral asymmetric
joint involvement, and extra-articular manifestations [1].
Enthesis is deﬁned as a site of insertion of tendons, liga-
ments, fascia, or articular capsule into bone. The involvement
of the entheses in any pathologic process, whether metabolic,
inﬂammatory, traumatic, or degenerative, is referred to as
enthesopathy, while the term ‘‘enthesitis’’ is restricted to
inﬂammation of the enthesis [2].
The enthesopathy of seronegative spondyloarthropathy
(SpA) is an example of entheseal involvement in a systemic
process. Peripheral enthesitis has been repeatedly described
in all forms of SpA and all phases of disease evolution [2,3].
It has been suggested that the presence of ﬁbrocartilage and
microtrauma are two major factors associated with disease
localisation in SpA [4]. A hypothesis that mechanically in-
duced enthesopathy may trigger autoimmunity towards ﬁbro-
cartilage/bone in HLA B27 positive patients has been
proposed on the basis of a strong correlation between the ex-
tent of bone pathology on MRI and the presence of HLA
B27, in patients with plantar fascia enthesopathy [5].
Accordingly, the Achilles tendon and plantar fascia, which
are the most commonly implicated sites in SpA-associated
enthesitis, along with the spinal ligaments usually affected by
the disease, have a prominent ﬁbrocartilage component [4].
Enthesitis may occur at any attachment site in SpA, but de-
tected enthesitis is more frequently depicted in the entheses of
the lower limbs, probably for mechanical reasons.
The ultrasound examination of these entheses conﬁrms the
frequency of their involvement [6–8].
Multiple imaging modalities are available to evaluate the
seronegative spondyloarthropathies. These include conven-
tional radiography, conventional tomography, computed
tomography (CT), magnetic resonance imaging (MRI), scintig-
raphy, and ultrasonography (US). Ultrasound is very cost efﬁ-
cient and does not convey radiation exposure that is inherent
to CT or conventional radiography. Compared with clinical
examination, ultrasound is superior in the detection of enthe-
seal abnormalities of the lower limbs in spondyloarthropathy
[6]. Previous studies reported the usefulness of US in theevaluation of the tendon and its insertional pathology [9,10]
with a sensitivity comparable to MRI [11,12].
The ﬁrst extensive description of entheseal involvement in
SpA patients by ultrasound was initially provided by Lehtinen
et al. [8] in 1994 followed by Balint et al. [6] in 2002 and
D’Agostino et al. [7] in 2003. Grey-scale enthesitis was mostly
characterised by the loss of normal ﬁbrillar echogenicity of the
tendon insertion (83%) with or without an increase in tendon
thickness or by intralesional focal changes at the tendon inser-
tion, such as calcium deposits, ﬁbrotic scars and periosteal
changes (erosions or new bone formation). The anatomical
borders of the enthesis are of capital importance. Some ultra-
sound studies studied enthesitis in the concept of ‘enthesis or-
gan’ leading sonographers to include the involvement of
surrounding structures far from the bony attachment (i.e. ten-
don and bursa) in the evaluation of enthesitis [13,14].
Our aim was to detect ultrasonographic entheseal abnor-
malities in the lower limb of patients with early spondyloarthr-
opathy and to evaluate US as an objective and reliable tool for
diagnosis of early entheseal involvement.
2. Patients and methods
Our study was performed on a total of 45 patients with a mean
age of 34.3 ± 6.22 years, early disease duration of
11.7 ± 8.5 months and 20 healthy controls matched for age
and sex with a mean of 36.9 ± 5.7 years, the control group
was without any known mechanical, inﬂammatory or muscu-
loskeletal disease. The patients included 10 with psoriatic
arthritis (PsA), 10 patients with ankylosing spondylitis (AS),
10 patients with reactive arthritis (ReA), eight patients with
ulcerative colitis (UC) and seven patients with Crohn’s disease.
All patients were diagnosed according to assessment in spond-
yloarthritis international society (ASAS) diagnostic criteria
[15].
All patients with PsA fulﬁlled the classiﬁcation criteria for
psoriatic arthritis (CASPAR) [16]. Endoscopic and histopath-
ologic diagnoses were performed in all patients with inﬂamma-
tory bowel disease (UC and Crohn’s disease). BASDAI score
was done to all patients with AS.
Ophthalmological examination including fundus and slit
lamp was done in all patients, in addition full laboratory and
X ray studies were performed to all patients that included a
complete blood cell count, biochemistry, C-reactive protein,
antinuclear antibodies, rheumatoid factor, HLA-B27 as well
as radiographs of the pelvis, sacroiliacs, tendo achillis, cervical,
dorsal and lumbar spine. Full musculoskeletal examination
was done to the all study group and the controls. All subjects
Table 1 Clinical laboratory and demographic characteristics of the studied groups of patients.
Characteristics PsA
N= 10
AS
N= 10
ReA
N= 10
UC
N= 8
Crohn’s disease
N= 7
Demographic data
Male, No. (%) 4 (40) 10 (100) 5 (50) 4 (33) 0
Female, No. (%) 7 (70) 0 0 8 (66) 7 (100)
Age* 50.9 ± 13.3 30.2 ± 2.9 27.8 ± 6.4 31.8 ± 7.1 37.6 ± 4.8
Disease duration/month* 12.5 ± 5.1 8.5 ± 5.2 3.3 ± 1.2 3.2 ± 2 3.3 ± 1.9
Clinical manifestations
Peripheral synovitis, No. (%) 5 (50) 4 (40) 7 (70) 2 (25) 2 (28.5)
Clinical enthesitis, No. (%) 4 (40) 2 (20) 5 (50) 1 (12.5) 1 (14.2)
Sacroilitis, No. (%) 4 (40) 8 (80) 4 (40) 1 (12.5) 2 (28)
Nail dystrophy, No. (%) 8 (80) 0 (0) 0 (0) 0 (0) 0 (0)
Spinal disease, No. (%) 3 (30) 10 (100) 3 (30) 1 (12.5) 2 (28)
Slit lamp changes, No. (%) 2 (20) 5 (50) 2 (40) 0 (0) 0 (0)
Laboratory manifestations
ESR, mm/Hg* 43.8 ± 6.9 33.5 ± 13 27 ± 6.2 48.2 ± 17.7 52.9 ± 19.1
CRP, mg/L* 33.7 ± 33.2 13.57 ± 11.5 12.2 ± 6.7 4.8 ± 1.1 8.4 ± 3.3
Haemoglobin (g %)* 12.7 ± 0.6 12.2 ± 1.1 9.9 ± 2.8 10.7 ± 2.6 9.3 ± 1.3
WBCs (·103/mm3)* 7.8 ± 1.4 7.8 ± 0.8 6.71 ± 1.5 11 ± 3.7 7.4 ± 1.1
Platelets (·103/mm3)* 272.7 ± 36.9 244 ± 28 260 ± 13.7 335 ± 75 208 ± 54.6
AST (U/L)* 19 ± 6.2 11 ± 3.2 12 ± 3.3 18 ± 14 13 ± 2.7
ALT (U/L)* 17.5 ± 1.2 17.2 ± 4.3 16.3 ± 4.3 18.2 ± 7.7 15.5 ± 5.1
Creatinine (mg/dl)* 0.8 ± 0.2 0.6 ± 0.001 0.7 ± 0.1 0.8 ± 0.2 0.6 ± 0.2
HLA-B27 + VE, No. (%) 4 (40) 9 (90) 5 (50) 2 (25) 2 (25)
Treatment, No. (%)
Methotrexate (mg/dl) 5 (50) 0 (0) 2 (20) 1 (12.5) 1(14.2)
Steroids (mg/dl) 0 (0) 0 (0) 0 (0) 7 (90) 7 (100)
Sulfasalazine 2 (20) 0 (0) 2 (40) 0 (0) 1 (14.2)
Mesalamine 0 (0) 0 (0) 0 (0) 8 (100) 7 (100)
Azathioprine 0 (0) 0 (0) 0 (0) 7 (90) 7 (100)
Anti-TNF 4 (40) 5 (50) 1 (10) 0 (0) 3 (42)
PsA: psoriatic arthritis; AS: ankylosing spondylitis; ReA: reactive arthritis; UC: ulcerative colitis, spinal disease: inﬂammatory back pain; ESR:
erythrocyte sedimentation rate; AST: aspartate transaminase; ALT: alanine transaminase; Rf: rheumatoid factor; HLA-B27: human leucocytic
antigen-B-27; TNF: tumour necrosis factor.
* Mean ± SD.
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sent. Patients were collected from the Rheumatology and
Rehabilitation Department, Cairo and Fayoum University
Hospitals.
2.1. Ultrasonography
Real-time ultrasonography was performed by both an experi-
enced radiologist and a rheumatologist, using an ATL HDI
3000 machine with a linear 7–12 MHz probe. The radiologist
was blinded, that is, he was not aware if patients were affected
by a rheumatological disease, and the ultrasonographic exam-
ination was performed in a darkened room. Examination of a
total of bilateral ﬁve entheseal lower limb sites was done with a
total of 450 entheseal sites including superior pole of the patel-
la (quadriceps tendon insertion), inferior pole of the patella
(patellar ligament origin) and the patellar ligament insertion
at the tibial tuberosity was performed with the patient in the
supine position with the knee ﬂexed at 30. The Achilles ten-
don and the plantar aponeurosis were examined with the pa-
tient lying prone with the feet hanging over the edge of the
examination table at 90 of ﬂexion. Ultrasonographic assess-
ment of structure, thickness and the presence or absence ofbony erosions, enthesophytes and bursitis was recorded at each
site. The following criteria were used for abnormal structure
thickness: quadriceps tendon thickness >6.1 mm (ref), proxi-
mal and distal patellar ligament >4 mm (ref), Achilles tendon
>5.29 mm (ref), plantar aponeurosis >4.4 mm (ref). Ultraso-
nographic ﬁndings were scored according to Glasgow Ultra-
sound Enthesitis Scoring System (GUESS), which was
validated by Balint et al. [6]. GUESS is an easily reproducible
standardised measure of lower limb entheseal ultrasonograph-
ic abnormalities, ranging from 0 to 36. It incorporates the
assessment of tendon thickness, and the presence of bone ero-
sions, enthesophytes and bursitis recorded at the Achilles,
quadriceps and patellar tendons and plantar aponeurosis.
Statistical analysis: Quantitative variables were described
using mean ± standard deviation (SD) and categorical data
by frequency and percentage. Pearson Chi-square test was
used to test differences amongst categorical variables amongst
the groups of patients and nonparametric Kruskal–Wallis test
was used to compare quantitative variables amongst the
groups. Fisher’s exact test was used to calculate an exact prob-
ability value for the relationship between two dichotomous
variables between positive and negative patients with respect
to enthesitis, and Student’s t test was used to compare quanti-
Table 2 Ultrasonographic enthesis involvement in patients
and controls.
Controls
n= 20
SpA group
n= 45
Signiﬁcance
GUESS score** 1.1 ± 0.2 6.8 ± 2.1 0.001*
Tendon thickened** 0.79 ± 1.28 0.91 ± 0.82 0.0001*
Bursitis** 0.67 ± 1.2 1.35 ± 1.29 0.003*
Enthesophyte** 3.2 ± 2.1 6.7 ± 3.69 0.002*
Bone erosion** 0 0 0
GUESS: Glasgow Ultrasound Enthesitis Scoring System.
* Signiﬁcantly different at p< 0.001.
** Mean ± SD.
32 Y. Ezzat et al.tative variables between groups of patients with respect to
enthesitis. In all tests, p value <0.05 was considered to be sta-
tistically signiﬁcant.3. Results
3.1. Demographic data
Our study included 45 patients with SpA, 23 males (51%) and
22 females (48.8%) with a mean age 34.3 ± 6.22 years and 20
healthy controls 11 males (55%) and nine females (45%) with
a mean age 36.9 ± 5.7 years. The average evolution time of the
spondyloarthritis group was 11.7 ± 8.5 months.
The mean ESR in SpA group was 11.19 ± 9.22 and C-reac-
tive protein (CRP) was 7.76 ± 11.6, antinuclear antibodies
and rheumatoid factor were negative in all patients, HLA-Table 3 Ultrasonographic examination of the Entheseal insertions
PsA
N= 10
AS
N= 10
GUESS score 4.5 ± 3 3.8 ± 1.6
Manifestations, No. (%)
Bursitis
Suprapatellar 4 (40) 0
Infrapatellar 6 (60) 1 (10)
Tibial tuberosity 3 (30) 5 (50)
Achilles tendon 1 (10) 3 (30)
Plantar aponeuroses 4 (40) 4 (40)
Enthesophytes
Suprapatellar 6 (60) 5 (50)
Infrapatellar 5 (50) 6 (60)
Tibial tuberosity 4 (40) 7 (70)
Achilles tendon 6 (60) 4 (40)
Plantar aponeuroses 6 (60) 3 (30)
Tendon thickened,* No. (%)
Suprapatellar 7 (70) 8 (80)
Infrapatellar 6 (60) 7 (70)
Tibial tuberosity 8 (80) 5 (50)
Achilles tendon 7 (70) 6 (60)
Plantar aponeuroses 6 (60) 7 (70)
* Suprapatellar (quadriceps tendon) >6.1 mm, infrapatellar (proximal p
>4 mm, Achilles tendon >5.29 mm, plantar aponeuroses >4.4 mm.B27 positivity was found in 22 patients (48%), the mean BAS-
DAI was 5.4 ± 2.8 in patients with AS.
On clinical examination of the entheseal sites of lower
limbs, we found inﬂammation in the form of tenderness and
swelling in a total of 13/45 (28.8%) patients. Peripheral syno-
vitis involving the knees and ankles was found in 20 (44%) pa-
tients, spinal disease in the form of inﬂammatory low back,
insidious onset, more than 3 month duration was found in
19 (42%) patients, radiographic sacroilitis was present in 19
(42%) patients. Slit lamp examination showed anterior uveitis
in nine (20%) patients. Detailed demographic, laboratory and
clinical characteristics of the study groups are illustrated in
Table 1.
3.2. Ultrasonographic results
All entheseal sites examined in the 20 control patient were nor-
mal, 450 entheseal sites in the 45 patients were examined by US
and showed a total of 290/450 (64.4%) of the entheseal sites
were abnormal (Table 3), Fig. 1 shows the ultrasonographic
ﬁndings of the entheses. Mean GUESS score was signiﬁcantly
higher in patients with SpA as compared with controls
(p< 0.001). The mean thickness of all tendons examined was
signiﬁcantly higher in SpA patients than in controls
(p< 0.0001) as well as the mean number of enthesophytes
and bursitis in all sites examined (p= 0.002, p= 0.003, respec-
tively) (Table 2), we did not observe bone erosions either in
cases or in controls. GUESS score was correlated to the dura-
tion of the disease in patients with SpA (p= 0.005), while there
was no signiﬁcant difference between GUESS score and either
the age, gender of the patients, ESR, CRP and HLA-B27 or the
clinical manifestations in the form of sacroilitis, spinal and eye
affection or nail changes and the BASDAI score.amongst SpA patients.
ReA
N= 10
UC
N= 8
Crohn’s disease
N= 7
5.8 ± 2.3 0.4 ± 0.7 0.6 ± 0.9
4 (40) 1 (12.5) 0
6 (60) 0 1 (14.2)
4 (40) 0 1 (14.2)
6 (60) 0 0
6 (60) 1 (12.5) 2 (28)
6 (60) 1 (12.5) 1 (14.2)
8 (80) 2 (25) 3 (42.8)
6 (60) 2 (25) 1 (14.2)
4 (40) 4 (50) 1 (14.2)
6 (60) 2 (25) 2 (28)
6 (60) 1 (12.5) 2 (28)
8 (80) 4 (50) 3 (42.8)
8 (80) 3 (37.5) 1 (14.2)
6 (60) 2 (25) 1 (14.2)
4 (40) 4 (50) 3 (37.5)
atellar ligament) >4 mm, tibial tuberosity (distal patellar ligament)
(A) (B)
(C) (D)
(E)
Figure 1 Ultrasonographic appearances of enthesitis, (A) inferior patellar enthesophyte, (B) thickened suprapatellar tendon, (C)
superior patellar enthesophyte, (D) infrapatellar bursitis, (E) planter enthesophyte.
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tween GUESS score and the anti-TNF medications used
amongst the selected groups (p< 0.001).
3.3. Differences between spondyloarthritis groups
The mean GUESS score was higher amongst patients with
PsA, ReA and AS (p= 0.001, p= 0.001, p= 0.002, respec-
tively). Ultrasonographic enthesiophytes, thickened tendons
and bursitis were found to be more common in PsA, and
ReA groups (p= 0.002, p= 0.01, respectively) while no
erosions were found amongst the examined groups. Detailed
ultrasonographic ﬁndings amongst the SpA groups are shown
in Table 3.4. Discussion
There is a growing interest in early diagnosis for patients with
spondyloarthropathy, all experts agree that enthesitis is a hall-
mark of spondyloarthropathy and that the detection of inﬂam-
matory changes in the joints is crucial to the diagnosis of the
seronegative spondyloarthropathies, especially early in the
disease course, when patients present with back pain of an
unknown cause [6,7].
The diagnostic validation of a technique implies several
steps, and in the case of enthesitis in SpA, at least two steps
are predominant and frequently evaluated at the same time:
the ability to distinguish between normal and abnormal ﬁnd-
ings at enthesis level and the capability of the tool for helping
34 Y. Ezzat et al.in the diagnostic process. In the ﬁeld of rheumatology, SpA is
one of the situations in which there is no reference standard
based on histological or biochemical changes, and the disease
condition is deﬁned by a combination of symptoms and signs
[17].
Therefore, the utility and accuracy of a new potentially use-
ful diagnosis test, such as ultrasound evaluation of enthesis,
can be difﬁcult to assess because of this important limitation.
In that case, the correct steps of validation of the test as well
as the design of an accuracy study are crucial [18], and for this
reason the OMERACT (Outcome Measures in Rheumatol-
ogy) Task Force produced the ﬁrst preliminary ultrasound
consensus deﬁnitions of the most frequently detected patholo-
gies [19]. The group at that time (2005) decided to deﬁne enthe-
sopathy instead of enthesitis, but is now working on a clear
deﬁnition of enthesitis in SpA [20].
The aim of our study focused to show if enthesis is a hall-
mark of early spondyloarthropathies, and if ultrasound can
be used to improve the accuracy of spondyloarthritis classiﬁca-
tion diagnosis.
In our current work ultrasound showed to be a sensitive
tool in detecting enthesitis, showing early entheseal inﬂamma-
tion in 290/450 (64.4%) of the entheseal sites in patients with
disease duration of 11.7 ± 8.5 months, in agreement, was de
Miguel et al. [21] who determined early entheseal affection in
SpA patients with US.
The mean GUESS score was found to be higher in SpA pa-
tients more than controls in addition to the mean of the thick-
ened tendons, enthesophytes and bursitis in all sites examined,
which shows that the entheses US score appears to be valid
and maybe useful for improving the diagnostic accuracy of
early SPA, in accordance with the results of the studies of
Secundini et al. [22] who studied the clinico-radiological corre-
lation of enthesis in seronegative SpA and Gerster [23] who
examined 150 patients with SpA and Balint et al. [6] who
showed that US GUESS score is superior in detecting enthe-
seal abnormalities in the lower limbs of SpA.
In our study, we observed that ultrasonographic enthesio-
phytes, thickened tendons and bursitis to be more common
in patients with PsA, and ReA, which suggest that a form of
subclinical synovitis may exist in these patients which can be
missed during routine clinical examination, these data were
conﬁrmed by Galluzzo et al. [24] who found a high prevalence
of involvement of the tendons and entheses of the ankle in clin-
ically asymptomatic PsA patients, suggesting that clinical eval-
uation underestimates these manifestations. GUESS score was
directly correlated to the duration of the disease in patients
with SpA but not the age or the gender of the patients, the role
of ageing on tendon thickness is uncertain, although more re-
cently it has been reported that Achilles tendon thickness was
similar in young and middle aged people [25]. Our study did
not show signiﬁcant difference between GUESS score and
HLA-B27 or BASDAI which coincides with the studies of
Rudwaleit et al. [26].
In our current work we had found a negative signiﬁcant
correlation between GUESS score and anti-TNF used
amongst SpA patients, in agreement were several data which
showed anti-TNF treatments to reduce spinal entheseal inﬂam-
mation [27,28].
In summary, enthesis involvement occurs early in spondyl-
oarthritis, the enthesis US score appears to be valid and useful
for improving the diagnostic accuracy of early SpA. However,further validation is still needed as US is an evolving tech-
nique. It should be kept in mind that differences in the US
equipment and settings, as well as correct knowledge of anat-
omy of enthesis may have an inﬂuence on the ability of US as a
diagnostic tool.Conﬂict of interest
The authors have no conﬂict of interest.References
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